[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Every home diagnostic devices", "description": "Well worth having these in the home and learning about your normal physiology. This is called your baseline. If you know your baseline physiology it becomes obvious if you are getting changed readings due to some disorder or infection.", "link": "https://www.youtube.com/watch?v=sZaprltEFxI", "date_published": "2022-09-27 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Post covid brain disorders", "description": "42%increased chance of developing a neuro problem after covid, equating to 7% of those infected.\n\nDr. Al-Aly\n\nOverall, COVID-19 has contributed to more than 40 million new cases of neurological disorders worldwide\n\nLong-term neurologic outcomes of COVID-19\n\nhttps://www.nature.com/articles/s41591-022-02001-z\n\nhttps://newatlas.com/health-wellbeing/mild-covid-risk-brain-neurological-problems/\n\nhttps://medicine.wustl.edu/news/covid-19-infections-increase-risk-of-long-term-brain-problems/\n\nComprehensive evaluation of postacute neurologic sequelae at 1 year\n\nNational healthcare databases of the US Department of Veterans Affairs\n\nCovid cohort = 154,068\n\n(nonhospitalized, hospitalized and admitted to intensive care)\n\nContemporary controls = 5,638,795\n\nHistorical controls = 5,859,621 (2017 data)\n\nAverage age of 61\n\nEstimate risks and burdens of incident neurologic disorders at 12 months following acute SARS-CoV-2 infection\n\nLongitudinal observational study design\n\nMarch 2020 through January 2021\n\n(predates delta, omicron and other COVID variants)\n\nResults\n\nIn the postacute phase of COVID-19, there was increased risk of an array of incident neurologic sequelae\n\nIschemic and hemorrhagic stroke\n\nTIA\n\nCognition and memory disorders\n\nPeripheral nervous system disorders\n\nEpisodic disorders (e.g. migraine, seizures)\n\nExtrapyramidal and movement disorders\n\nMental health disorders, (anxiety depression psychosis)\n\nMusculoskeletal disorders\n\nSensory disorders\n\nGuillain\u2013Barr\u00e9 syndrome\n\nEncephalitis or encephalopathy\n\nHeadaches\n\nHazard ratio of any neurologic sequela\n\n1.42 (1.38 to 1.47)\n\nBurden\n\n70.69 (63.54 to 78.01) per 1,000 persons at 12 months\n\nOr, 7.069%\n\nThe risks and burdens were elevated even in people who did not require hospitalization during acute COVID-19\n\nRisks and burdens increased according to the severity of the acute infection,\n\nfrom nonhospitalized to hospitalized to intensive care\n\nDizzynes\n\nTaken together, our results provide evidence of increased risk of long-term neurologic disorders in people who had COVID-19.\n\nIncident neurologic outcomes in COVID-19 versus contemporary control\n\nCerebrovascular disorders (at 12 months)\n\nIschemic stroke HR 1.50, burden 3.40 per 1,000 \n\nTransient ischemic attacks HR 1.62, burden 2.03 \n\nHemorrhagic stroke HR 2.19, burden 0.21\n\nCerebral venous thrombosis HR 2.69, burden 0.05\n\nComposite of these cerebrovascular outcomes were HR 1.56, burden 4.92\n\nCognition and memory\n\nRisks of memory problems HR 1.77, burden 10.07\n\nAlzheimer\u2019s disease HR 2.03, burden 1.65\n\nComposite of these cognition and memory outcomes were HR 1.80, Burden 10.35\n\nDisorders of peripheral nerves\n\nPeripheral neuropathy HR 1.34, burden 5.64\n\nParesthesia HR 1.32, burden 2.89\n\nDysautonomia HR 1.30, burden 1.60\n\nBell\u2019s palsy HR 1.48, burden 0.32\n\nComposite of these disorders of peripheral nerves were HR 1.34, burden 8.64\n\nEpisodic disorders\n\nMigraine, epilepsy and seizures, headache disorders\n\nComposite of these episodic disorders were HR 1.32, burden 4.75\n\nExtrapyramidal and movement disorders\n\nAbnormal involuntary movements, tremor, Parkinson-like disease, dystonia, myoclonus\n\nComposite of these extrapyramidal and movement disorders were HR 1.42, burden 3.98\n\n\nMental health disorders\n\nMajor depressive disorders, stress and adjustment disorders, anxiety disorders, psychotic disorders\n\nComposite of these mental health disorders were HR 1.43, burden 25.00\n\nMusculoskeletal disorders\n\nJoint pain, myalgia, myopathy\n\nComposite of these musculoskeletal disorders were HR 1.45, burden 40.09\n\nSensory disorders\n\nHearing abnormalities, tinnitus, vision abnormalities, loss of smell, loss of taste\n\nComposite of these sensory disorders were HR 1.25, burden 17.03 \n\nOther neurologic or related disorders\n\nDizziness, somnolence, Guillain\u2013Barr\u00e9 syndrome, encephalitis or encephalopathy, transverse myelitis\n\nComposite of these other neurologic or related disorders were HR 1.46, burden 7.37\n\nComposite outcome of any neurologic disorder\n\nCompared with the contemporary control group, there was increased risk and burden of any neurologic outcome\n\nHR 1.42, burden 70.69\n\nDr. Al-Aly\nIt doesn\u2019t matter if you are young or old, female or male, or what your race is. It doesn\u2019t matter if you smoked or not, or if you had other unhealthy habits or conditions.", "link": "https://www.youtube.com/watch?v=yF4PebYeYpU", "date_published": "2022-09-26 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]